Dorzolamide
Back to searchMolecule Structure
Scientific Name
Dorzolamide
Description of the Drug
Dorzolamide is a carbonic anhydrase inhibitor used to treat high intraocular pressure in ocular hypertension and open angle glaucoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00869
http://www.drugbank.ca/drugs/DB00869
Brand Name(s)
Dorzant, Trusopt
Company Owner(s)
Micro Labs Ltd, Thea Pharma Inc, Rubicon Research Private Ltd, Alembic Pharmaceuticals Ltd, Akorn Operating Co Llc, Fdc Ltd, Sandoz Inc, Zambon Spa, Gland Pharma Ltd, American Regent Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Carbonic anhydrase II | SINGLE PROTEIN | INHIBITOR | CHEMBL205 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL24061 | ||
| Human Metabolome Database | HMDB0015007 | ||
| DrugBank | DB00869 | ||
| PubChem: Thomson Pharma | 14752891 | 14752890 | |
| PubChem | 5284549 | ||
| LINCS | LSM-5597 | ||
| Nikkaji | J488.895B | ||
| PDBe | ETS | ||
| BindingDB | 10884 | ||
| EPA CompTox Dashboard | DTXSID7022960 | ||
| DrugCentral | 949 | ||
| Brenda | 226397 | 197369 | 37705 |
| Guide to Pharmacology | 6810 | ||
| rxnorm | DORZOLAMIDE | TRUSOPT | DORZOLAMIDE HYDROCHLORIDE |
| KEGG Ligand | C06969 | ||
| ChEBI | 4702 | ||
| ZINC | ZINC000001530621 |
